Source:http://linkedlifedata.com/resource/pubmed/id/16196104
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-1-17
|
pubmed:abstractText |
In this study, we describe a differential mass spectrometric technique for the immuno-proteomic analysis of the major histocompatibility complex (MHC) peptides of a renal cell carcinoma (RCC) biopsy compared with the healthy kidney tissue of the same patient after nephrectomy. Using a stable isotope labeling approach, we could directly compare and relatively quantify 43 MHC-peptide pairs, most of which were present in similar proportions on both normal kidney and tumor. Significantly, two dominant peptides of monoisotopic masses ([M+H](+)) 973.43 u and 967.59 u, respectively, were found exclusively in the tumor sample. One of these was identified as originating from heme oxygenase-1 (HO-1), a protein involved in induction of apoptosis resistance, immuno-suppression and neoangiogenesis and reported to be up-regulated in various cancer types. Moreover, the corresponding synthetic HO-1-derived peptide was shown to be immunogenic in vitro by generation of CD8+ T cell lines with peptide-specific cytolytic activity. Thus, this peptide is an example of a differentially identified T cell epitope that could be considered as a target for immunotherapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1615-9853
|
pubmed:author |
pubmed-author:BeckAlexanderA,
pubmed-author:BogumilRalfR,
pubmed-author:DihaziHassanH,
pubmed-author:FladThomasT,
pubmed-author:GrigorovaVenetaV,
pubmed-author:KalbacherHubertH,
pubmed-author:MuellerClaudia ACA,
pubmed-author:MuellerGerhard AGA,
pubmed-author:MuellerLudmilaL,
pubmed-author:ThedieckCorneliaC
|
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
364-74
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:16196104-Aged,
pubmed-meshheading:16196104-Chromatography, High Pressure Liquid,
pubmed-meshheading:16196104-Epitopes,
pubmed-meshheading:16196104-Female,
pubmed-meshheading:16196104-HLA-B8 Antigen,
pubmed-meshheading:16196104-Humans,
pubmed-meshheading:16196104-Immunohistochemistry,
pubmed-meshheading:16196104-Interferon-gamma,
pubmed-meshheading:16196104-Kidney Neoplasms,
pubmed-meshheading:16196104-Ligands,
pubmed-meshheading:16196104-Mass Spectrometry,
pubmed-meshheading:16196104-Nanotechnology,
pubmed-meshheading:16196104-T-Lymphocytes
|
pubmed:year |
2006
|
pubmed:articleTitle |
T cell epitope definition by differential mass spectrometry: identification of a novel, immunogenic HLA-B8 ligand directly from renal cancer tissue.
|
pubmed:affiliation |
Section for Transplantation Immunology and Immunohematology, University of Tuebingen, Waldhoernlestrasse 22, 72072 Tuebingen, Germany. thomas.flad@gmx.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|